Acute myeloid leukemia with translocation t(3;5): new molecular insights
- 12 February 2013
- journal article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 98 (4) , e52-e54
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French AssociationLeukemia, 2012
- Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trialsBlood, 2010
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changesBlood, 2009
- NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemiaHaematologica, 2008
- Loss of the NPM1 gene in myeloid disorders with chromosome 5 rearrangementsLeukemia, 2005
- Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significanceBlood, 2005
- Cytoplasmic Nucleophosmin in Acute Myelogenous Leukemia with a Normal KaryotypeNew England Journal of Medicine, 2005
- Elevated MLF1 expression correlates with malignant progression from myelodysplastic syndromeLeukemia, 2000
- The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1.1996
- CLINICOPATHOLOGIC MANIFESTATIONS AND BREAKPOINTS OF THE T(3-5) IN PATIENTS WITH ACUTE NONLYMPHOCYTIC LEUKEMIA1989